SlideShare una empresa de Scribd logo
1 de 20
Providing Consultancy &
Research in Health Economics
Julie Glanville, York Health Economics Consortium, UK
Gordon Dooley, Metaxis, UK
Anna Noel Storr, Cochrane Dementia and Cognitive Improvement Group
Ruth Foxlee, Cochrane Editorial Unit
October 2015
Improving rapid access to reports of
RCTs from Embase: innovative
methods to enhance the Cochrane
Central Register of Controlled Trials
(CENTRAL)
Providing Consultancy &
Research in Health Economics
Presentation Overview
 Background
 Objectives
 Methods
 Results
 The future
Background
 Cochrane systematic reviews rely on the efficient identification of
research evidence, specifically evidence from randomised
controlled trials (RCTs) and quasi randomised studies.
 The largest single source of RCTs is the Cochrane Central Register
of Controlled Trials (CENTRAL)
 CENTRAL was mainly populated with records from Medline, but
also contained records from Embase
 Collaboration identified the need for improved rapid identification of
trials from Embase for inclusion in CENTRAL
The project and its
objectives
 The Cochrane Collaboration commissioned the Embase update
project in March 2013
 Project is undertaken by a consortium of three organisations
 the Cochrane Dementia and Cognitive Improvement Group
 Metaxis, UK
 York Health Economics Consortium. University of York, UK
 Objectives
 To identify reports of RCTs and controlled clinical trials from
Embase for more rapid availability in CENTRAL
 Today I will report on the development of the bespoke search filter
to identify the trials
Methods, 1
 We developed and validated a sensitive search filter to identify
reports of RCTs
 Reference standard of 10,000 randomly selected relevant Embase
reports of RCTs and quasi RCTs already available in CENTRAL
was compiled.
 published 2000-2010
 Used Simstatw and Wordstatw to Identify terms, phrases and
grouped terms within that reference standard set of records
which could be tested in filters
Methods, 2: techniques for
identifying candidate terms
 The frequency of terms which appeared in more than 10 records.
Terms were analysed by their location within a record: title,
abstract, EMTREE headings. Also all terms (independent of their
location within a record) were analysed by frequency.
 The WordStat phrase finding option was used to identify phrases
which appeared in more than 10 records.
 Case occurrence and term frequency–inverse document frequency
(tf*idf) were tested.
 WordStat clustering option to identify terms which form groups, i.e.
words which often appear in close proximity to each other.
Methods, 3: testing and
validation
 Draft strategies were tested on a second set of 10,000 randomly
selected Embase RCT records from CENTRAL
 The best candidate filter was validated against a third set of 10,000
randomly selected Embase RCT records from CENTRAL
 We also assessed the performance of the filter against the previous
Cochrane filter
Methods, 3: 2015 revision
 Cochrane 2014 strategy was revised and a range of exclusion
terms were added
 These were identified from the rejected studies
 Subject terms and also animal terms
 The impact of the exclusions was tested
 The revised strategy was adopted from February 2015 onwards
 This summer we have developed a filter just to remove animal
studies presented as conference papers
Results (reference standard 3)
 The validated search filter identifies reports of RCTs in
Embase with over 97.6% sensitivity
 97.6% in records published in 2002 (reference standard 3)
 100% in records published in 2010 (reference standard 3)
 Number needed to read
 156 (records published in 2001)
 400 (records published in 2010)
Embase Filter (Ovid
interface) 2014
1. Randomized controlled trial/
2. Controlled clinical study/
3. 1 or 2
4. Random$.ti,ab.
5. randomization/
6. intermethod comparison/
7. placebo.ti,ab.
8. (compare or compared or comparison).ti.
9. ((evaluated or evaluate or evaluating or
assessed or assess) and (compare or
compared or comparing or
comparison)).ab.
10. (open adj label).ti,ab.
11. ((double or single or doubly or singly) adj
(blind or blinded or blindly)).ti,ab.
12. double blind procedure/
13. parallel group$1.ti,ab.
14. (crossover or cross over).ti,ab.
15. ((assign$ or match or matched or
allocation) adj5 (alternate or group$1 or
intervention$1 or patient$1 or subject$1
or participant$1)).ti,ab.
16. (assigned or allocated).ti,ab.
17. (controlled adj7 (study or design or
trial)).ti,ab.
18. (volunteer or volunteers).ti,ab.
19. human experiment/
20. trial.ti.
21. or/4-20
22. 21 not 3
Process
 An analysis of the records retrieved resulted in a tiered
record assessment process
 The most obvious RCT reports are fast-tracked into CENTRAL
 Animal studies are set to one side for team assessment
 The less obvious RCT records are assessed for relevance by
internet crowdsourcing
 Record screening software written by Metaxis
 Between two and six people assess whether a record is really a
report of an RCT
Performance against
original Cochrane filter
 The Cochrane 2014 filter found 71,448 records that were not
retrieved by the original Cochrane filter:
 1000 of the most recent records were obtained for assessment.
 9.1% were possibly reports of CCTs or RCTs
 If this % is extrapolated to the 71,448 unique records retrieved by the
Cochrane 2014 filter then 6500 extra reports of RCTs might be identifed
by this filter
 The original filter found 988/1000 records that were not retrieved by
the Cochrane 2014 filter: all of these records were downloaded.
 3% of these records were possibly reports of controlled clinical trials
 The records found by both filters totalled 33,360.
Cochrane 2015 filter
 The following two slides show the search
terms which are excluded from the results
of the Cochrane 2014 filter
1. Cochrane 2014 filter
2. Exclusions (2015)
3. 1 NOT 2
Cochrane 2015 filter
exclusions, 1
 (random$ adj sampl$ adj7 ("cross section$" or questionnaire$1 or
survey$ or database$1)).ti,ab. not (comparative study/ or controlled
study/ or randomi?ed controlled.ti,ab. or randomly assigned.ti,ab.)
(5813)
 Cross-sectional study/ not (randomized controlled trial/ or controlled
clinical study/ or controlled study/ or randomi?ed controlled.ti,ab. or
control group$1.ti,ab.) (100831)
 (((case adj control$) and random$) not randomi?ed controlled).ti,ab.
(10405)
 (Systematic review not (trial or study)).ti. (44089)
 (nonrandom$ not random$).ti,ab. (11950)
 "Random field$".ti,ab. (1294)
 (random cluster adj3 sampl$).ti,ab. (703)
Cochrane 2015 filter
 (review.ab. and review.pt.) not trial.ti. (480641)
 "we searched".ab. and (review.ti. or review.pt.) (13032)
 "update review".ab. (64)
 (databases adj4 searched).ab. (11423)
 (rat or rats or mouse or mice or swine or porcine or murine or sheep
or lambs or pigs or piglets or rabbit or rabbits or cat or cats or dog
or dogs or cattle or bovine or monkey or monkeys or trout or
marmoset$1).ti. and animal experiment/ (819059)
 Animal experiment/ not (human experiment/ or human/) (1669138)
 ((In vitro or invitro) not (invivo or "in vivo")).ti. (239064)
 or/1-14 (2553242)
Embase processing
January 2014-end Jan 2015 using Cochrane 2014 filter
February 2015-July 2015 using revised filter
Jan 2014 to 31
Jan 2015
Feb 2015-
July 2015
inclusive
Total retrieved 153610 78516
Records sent directly into
Central 54282 9607
Screened RCT or CCT 4324 4515
Screened Reject 94095 63900
Screened Unsure 909 494
Study identification:
precision
Jan 2014 to 31
Jan 2015
Feb 2015-July
2015 inclusive
Precision: all records 38.15% 17.99%
Precision: screened records 4.55% 7.01%
NNR all RCT/CCT records 2.621063 5.559836
NNR screened records only 21.97132 14.26224
January 2014-end Jan 2015 using Cochrane 2014 filter
February 2015-July 2015 using revised filter
Summary
 Many next steps including exploring text mining options
 We have achieved improved currency of Embase record
availability in CENTRAL
 The number of irrelevant and duplicate records will be
fewer
 Searchers will be able to identify more RCTs more
accurately than previously by a rapid search of
CENTRAL
We need help!
 Please visit our project website
 http://www.metaxis.com/embasepublic/
Feel free to join the crowd!
http://www.metaxis.com/embase/login.php
Providing Consultancy &
Research in Health Economics
http://tinyurl.com/yhec-facebook
http://twitter.com/YHEC1
http://www.minerva-network.com/
Thank you
julie.glanville@york.ac.uk
Telephone: +44 1904 324832
Website: www.yhec.co.uk

Más contenido relacionado

La actualidad más candente

Association between delayed initiation of adjuvant CMF or anthracycline-based...
Association between delayed initiation of adjuvant CMF or anthracycline-based...Association between delayed initiation of adjuvant CMF or anthracycline-based...
Association between delayed initiation of adjuvant CMF or anthracycline-based...Enrique Moreno Gonzalez
 
Cochrane Library_intro
Cochrane Library_introCochrane Library_intro
Cochrane Library_introLee Vucovich
 
The cochrane library an introduction for rheumatologists - 17 feb 2014
The cochrane library   an introduction for rheumatologists - 17 feb 2014The cochrane library   an introduction for rheumatologists - 17 feb 2014
The cochrane library an introduction for rheumatologists - 17 feb 2014Tamara Rader
 
SWAT4LS Open PHACTS Explorer demonstration
SWAT4LS Open PHACTS Explorer demonstrationSWAT4LS Open PHACTS Explorer demonstration
SWAT4LS Open PHACTS Explorer demonstrationthetravellingbard
 
Ht ai 2015 poster 238 - Efficiency of the Artificial Urinary Sphincter
Ht ai 2015 poster 238 - Efficiency of the Artificial Urinary SphincterHt ai 2015 poster 238 - Efficiency of the Artificial Urinary Sphincter
Ht ai 2015 poster 238 - Efficiency of the Artificial Urinary SphincterREBRATSoficial
 
Automated versus non automated weaning
Automated versus non automated weaningAutomated versus non automated weaning
Automated versus non automated weaningAngelo Roncalli
 
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...IJDKP
 
Predicting volume of distribution for drug compounds using decision trees
Predicting volume of distribution for drug compounds using decision treesPredicting volume of distribution for drug compounds using decision trees
Predicting volume of distribution for drug compounds using decision treesNithyakalyani Chinnaiah
 
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Zoe Mitchell
 
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...Yasser Sami Abdel Dayem Amer
 
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Office of Health Economics
 
School of pharmacy univ washington epidemiolgy-bio statistics- health econo...
School of pharmacy univ  washington  epidemiolgy-bio statistics- health econo...School of pharmacy univ  washington  epidemiolgy-bio statistics- health econo...
School of pharmacy univ washington epidemiolgy-bio statistics- health econo...M. Luisetto Pharm.D.Spec. Pharmacology
 
Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Zoe Mitchell
 
Final spring practicum 6 apr10
Final spring practicum 6 apr10Final spring practicum 6 apr10
Final spring practicum 6 apr10pgeisen
 
Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012
Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012
Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012Vadim Tantsyura
 
Comparison of registered and published intervention fidelity assessment in cl...
Comparison of registered and published intervention fidelity assessment in cl...Comparison of registered and published intervention fidelity assessment in cl...
Comparison of registered and published intervention fidelity assessment in cl...valéry ridde
 
Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Dr. Ganesh Divekar
 

La actualidad más candente (20)

Association between delayed initiation of adjuvant CMF or anthracycline-based...
Association between delayed initiation of adjuvant CMF or anthracycline-based...Association between delayed initiation of adjuvant CMF or anthracycline-based...
Association between delayed initiation of adjuvant CMF or anthracycline-based...
 
Cochrane Library_intro
Cochrane Library_introCochrane Library_intro
Cochrane Library_intro
 
MCC 2011 - Slide 24
MCC 2011 - Slide 24MCC 2011 - Slide 24
MCC 2011 - Slide 24
 
The cochrane library an introduction for rheumatologists - 17 feb 2014
The cochrane library   an introduction for rheumatologists - 17 feb 2014The cochrane library   an introduction for rheumatologists - 17 feb 2014
The cochrane library an introduction for rheumatologists - 17 feb 2014
 
SWAT4LS Open PHACTS Explorer demonstration
SWAT4LS Open PHACTS Explorer demonstrationSWAT4LS Open PHACTS Explorer demonstration
SWAT4LS Open PHACTS Explorer demonstration
 
Ht ai 2015 poster 238 - Efficiency of the Artificial Urinary Sphincter
Ht ai 2015 poster 238 - Efficiency of the Artificial Urinary SphincterHt ai 2015 poster 238 - Efficiency of the Artificial Urinary Sphincter
Ht ai 2015 poster 238 - Efficiency of the Artificial Urinary Sphincter
 
Automated versus non automated weaning
Automated versus non automated weaningAutomated versus non automated weaning
Automated versus non automated weaning
 
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
 
Comparative efficacy of interventions to promote hand hygiene in hospital sys...
Comparative efficacy of interventions to promote hand hygiene in hospital sys...Comparative efficacy of interventions to promote hand hygiene in hospital sys...
Comparative efficacy of interventions to promote hand hygiene in hospital sys...
 
Predicting volume of distribution for drug compounds using decision trees
Predicting volume of distribution for drug compounds using decision treesPredicting volume of distribution for drug compounds using decision trees
Predicting volume of distribution for drug compounds using decision trees
 
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
 
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
 
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
 
Data management & statistics in clinical trials
Data management & statistics in clinical trialsData management & statistics in clinical trials
Data management & statistics in clinical trials
 
School of pharmacy univ washington epidemiolgy-bio statistics- health econo...
School of pharmacy univ  washington  epidemiolgy-bio statistics- health econo...School of pharmacy univ  washington  epidemiolgy-bio statistics- health econo...
School of pharmacy univ washington epidemiolgy-bio statistics- health econo...
 
Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?
 
Final spring practicum 6 apr10
Final spring practicum 6 apr10Final spring practicum 6 apr10
Final spring practicum 6 apr10
 
Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012
Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012
Cost-Effective Approach to Managing Lab RR for Local Laboratories in CR, 2012
 
Comparison of registered and published intervention fidelity assessment in cl...
Comparison of registered and published intervention fidelity assessment in cl...Comparison of registered and published intervention fidelity assessment in cl...
Comparison of registered and published intervention fidelity assessment in cl...
 
Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20
 

Similar a Improving Access to RCT Reports from Embase

Nursing Research Resources
Nursing Research Resources Nursing Research Resources
Nursing Research Resources Ann Celestine
 
IJPCR,Vol15,Issue6,Article137.pdf
IJPCR,Vol15,Issue6,Article137.pdfIJPCR,Vol15,Issue6,Article137.pdf
IJPCR,Vol15,Issue6,Article137.pdfdrdivyeshgoswami1
 
Embase webinar pico search strategies as of 042115v3
Embase webinar pico search strategies as of 042115v3Embase webinar pico search strategies as of 042115v3
Embase webinar pico search strategies as of 042115v3Ann-Marie Roche
 
Planning A Study - Spirit Week Survey
Planning A Study - Spirit Week SurveyPlanning A Study - Spirit Week Survey
Planning A Study - Spirit Week Surveyguesta957af1
 
Planning A Study: Spirit Week Survey
Planning A Study: Spirit Week SurveyPlanning A Study: Spirit Week Survey
Planning A Study: Spirit Week Surveyguesta957af1
 
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...Vaticle
 
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...Wei Garofolo
 
C:\Documents And Settings\Biblioteca\Escritorio\ New Look Tcl
C:\Documents And Settings\Biblioteca\Escritorio\  New Look TclC:\Documents And Settings\Biblioteca\Escritorio\  New Look Tcl
C:\Documents And Settings\Biblioteca\Escritorio\ New Look TclJosé Francisco Simó Martínez
 
Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012
Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012
Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012Ann-Marie Roche
 
Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...
Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...
Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...World Cancer Research Fund International
 
Frictional resistance in self ligating orthodontic brackets and conventionall...
Frictional resistance in self ligating orthodontic brackets and conventionall...Frictional resistance in self ligating orthodontic brackets and conventionall...
Frictional resistance in self ligating orthodontic brackets and conventionall...VARADARAJU MAGESH
 

Similar a Improving Access to RCT Reports from Embase (20)

Nursing Research Resources
Nursing Research Resources Nursing Research Resources
Nursing Research Resources
 
IJPCR,Vol15,Issue6,Article137.pdf
IJPCR,Vol15,Issue6,Article137.pdfIJPCR,Vol15,Issue6,Article137.pdf
IJPCR,Vol15,Issue6,Article137.pdf
 
Embase webinar pico search strategies as of 042115v3
Embase webinar pico search strategies as of 042115v3Embase webinar pico search strategies as of 042115v3
Embase webinar pico search strategies as of 042115v3
 
Overview of Evidence Based Medicine and Systematic Review Methodology
Overview of Evidence Based Medicine and Systematic Review MethodologyOverview of Evidence Based Medicine and Systematic Review Methodology
Overview of Evidence Based Medicine and Systematic Review Methodology
 
ARRIVE Guidelines
ARRIVE GuidelinesARRIVE Guidelines
ARRIVE Guidelines
 
Refl
ReflRefl
Refl
 
Planning A Study - Spirit Week Survey
Planning A Study - Spirit Week SurveyPlanning A Study - Spirit Week Survey
Planning A Study - Spirit Week Survey
 
Planning A Study: Spirit Week Survey
Planning A Study: Spirit Week SurveyPlanning A Study: Spirit Week Survey
Planning A Study: Spirit Week Survey
 
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...
 
2014 abstracs.pdf
2014 abstracs.pdf2014 abstracs.pdf
2014 abstracs.pdf
 
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
Recommendations on ISR in multi‐analyte assays, QA/bioanalytical consultants ...
 
A.Muenzenmeyer_AACC_2016
A.Muenzenmeyer_AACC_2016A.Muenzenmeyer_AACC_2016
A.Muenzenmeyer_AACC_2016
 
OER_s1220738.pptx
OER_s1220738.pptxOER_s1220738.pptx
OER_s1220738.pptx
 
C:\Documents And Settings\Biblioteca\Escritorio\ New Look Tcl
C:\Documents And Settings\Biblioteca\Escritorio\  New Look TclC:\Documents And Settings\Biblioteca\Escritorio\  New Look Tcl
C:\Documents And Settings\Biblioteca\Escritorio\ New Look Tcl
 
Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012
Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012
Embase - Supporting Evidence Based Medicine - Webinar 24 Oct 2012
 
Nutr08009 l3
Nutr08009 l3Nutr08009 l3
Nutr08009 l3
 
Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...
Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...
Novel method for reviewing mechanistic evidence on diet, nutrition, physical ...
 
Frictional resistance in self ligating orthodontic brackets and conventionall...
Frictional resistance in self ligating orthodontic brackets and conventionall...Frictional resistance in self ligating orthodontic brackets and conventionall...
Frictional resistance in self ligating orthodontic brackets and conventionall...
 
London 2008
London 2008London 2008
London 2008
 
Internal 2014 - Cochrane data
Internal 2014 - Cochrane dataInternal 2014 - Cochrane data
Internal 2014 - Cochrane data
 

Último

Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxCulture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxPoojaSen20
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 

Último (20)

Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxCulture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 

Improving Access to RCT Reports from Embase

  • 1. Providing Consultancy & Research in Health Economics Julie Glanville, York Health Economics Consortium, UK Gordon Dooley, Metaxis, UK Anna Noel Storr, Cochrane Dementia and Cognitive Improvement Group Ruth Foxlee, Cochrane Editorial Unit October 2015 Improving rapid access to reports of RCTs from Embase: innovative methods to enhance the Cochrane Central Register of Controlled Trials (CENTRAL)
  • 2. Providing Consultancy & Research in Health Economics Presentation Overview  Background  Objectives  Methods  Results  The future
  • 3. Background  Cochrane systematic reviews rely on the efficient identification of research evidence, specifically evidence from randomised controlled trials (RCTs) and quasi randomised studies.  The largest single source of RCTs is the Cochrane Central Register of Controlled Trials (CENTRAL)  CENTRAL was mainly populated with records from Medline, but also contained records from Embase  Collaboration identified the need for improved rapid identification of trials from Embase for inclusion in CENTRAL
  • 4. The project and its objectives  The Cochrane Collaboration commissioned the Embase update project in March 2013  Project is undertaken by a consortium of three organisations  the Cochrane Dementia and Cognitive Improvement Group  Metaxis, UK  York Health Economics Consortium. University of York, UK  Objectives  To identify reports of RCTs and controlled clinical trials from Embase for more rapid availability in CENTRAL  Today I will report on the development of the bespoke search filter to identify the trials
  • 5. Methods, 1  We developed and validated a sensitive search filter to identify reports of RCTs  Reference standard of 10,000 randomly selected relevant Embase reports of RCTs and quasi RCTs already available in CENTRAL was compiled.  published 2000-2010  Used Simstatw and Wordstatw to Identify terms, phrases and grouped terms within that reference standard set of records which could be tested in filters
  • 6. Methods, 2: techniques for identifying candidate terms  The frequency of terms which appeared in more than 10 records. Terms were analysed by their location within a record: title, abstract, EMTREE headings. Also all terms (independent of their location within a record) were analysed by frequency.  The WordStat phrase finding option was used to identify phrases which appeared in more than 10 records.  Case occurrence and term frequency–inverse document frequency (tf*idf) were tested.  WordStat clustering option to identify terms which form groups, i.e. words which often appear in close proximity to each other.
  • 7. Methods, 3: testing and validation  Draft strategies were tested on a second set of 10,000 randomly selected Embase RCT records from CENTRAL  The best candidate filter was validated against a third set of 10,000 randomly selected Embase RCT records from CENTRAL  We also assessed the performance of the filter against the previous Cochrane filter
  • 8. Methods, 3: 2015 revision  Cochrane 2014 strategy was revised and a range of exclusion terms were added  These were identified from the rejected studies  Subject terms and also animal terms  The impact of the exclusions was tested  The revised strategy was adopted from February 2015 onwards  This summer we have developed a filter just to remove animal studies presented as conference papers
  • 9. Results (reference standard 3)  The validated search filter identifies reports of RCTs in Embase with over 97.6% sensitivity  97.6% in records published in 2002 (reference standard 3)  100% in records published in 2010 (reference standard 3)  Number needed to read  156 (records published in 2001)  400 (records published in 2010)
  • 10. Embase Filter (Ovid interface) 2014 1. Randomized controlled trial/ 2. Controlled clinical study/ 3. 1 or 2 4. Random$.ti,ab. 5. randomization/ 6. intermethod comparison/ 7. placebo.ti,ab. 8. (compare or compared or comparison).ti. 9. ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab. 10. (open adj label).ti,ab. 11. ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab. 12. double blind procedure/ 13. parallel group$1.ti,ab. 14. (crossover or cross over).ti,ab. 15. ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab. 16. (assigned or allocated).ti,ab. 17. (controlled adj7 (study or design or trial)).ti,ab. 18. (volunteer or volunteers).ti,ab. 19. human experiment/ 20. trial.ti. 21. or/4-20 22. 21 not 3
  • 11. Process  An analysis of the records retrieved resulted in a tiered record assessment process  The most obvious RCT reports are fast-tracked into CENTRAL  Animal studies are set to one side for team assessment  The less obvious RCT records are assessed for relevance by internet crowdsourcing  Record screening software written by Metaxis  Between two and six people assess whether a record is really a report of an RCT
  • 12. Performance against original Cochrane filter  The Cochrane 2014 filter found 71,448 records that were not retrieved by the original Cochrane filter:  1000 of the most recent records were obtained for assessment.  9.1% were possibly reports of CCTs or RCTs  If this % is extrapolated to the 71,448 unique records retrieved by the Cochrane 2014 filter then 6500 extra reports of RCTs might be identifed by this filter  The original filter found 988/1000 records that were not retrieved by the Cochrane 2014 filter: all of these records were downloaded.  3% of these records were possibly reports of controlled clinical trials  The records found by both filters totalled 33,360.
  • 13. Cochrane 2015 filter  The following two slides show the search terms which are excluded from the results of the Cochrane 2014 filter 1. Cochrane 2014 filter 2. Exclusions (2015) 3. 1 NOT 2
  • 14. Cochrane 2015 filter exclusions, 1  (random$ adj sampl$ adj7 ("cross section$" or questionnaire$1 or survey$ or database$1)).ti,ab. not (comparative study/ or controlled study/ or randomi?ed controlled.ti,ab. or randomly assigned.ti,ab.) (5813)  Cross-sectional study/ not (randomized controlled trial/ or controlled clinical study/ or controlled study/ or randomi?ed controlled.ti,ab. or control group$1.ti,ab.) (100831)  (((case adj control$) and random$) not randomi?ed controlled).ti,ab. (10405)  (Systematic review not (trial or study)).ti. (44089)  (nonrandom$ not random$).ti,ab. (11950)  "Random field$".ti,ab. (1294)  (random cluster adj3 sampl$).ti,ab. (703)
  • 15. Cochrane 2015 filter  (review.ab. and review.pt.) not trial.ti. (480641)  "we searched".ab. and (review.ti. or review.pt.) (13032)  "update review".ab. (64)  (databases adj4 searched).ab. (11423)  (rat or rats or mouse or mice or swine or porcine or murine or sheep or lambs or pigs or piglets or rabbit or rabbits or cat or cats or dog or dogs or cattle or bovine or monkey or monkeys or trout or marmoset$1).ti. and animal experiment/ (819059)  Animal experiment/ not (human experiment/ or human/) (1669138)  ((In vitro or invitro) not (invivo or "in vivo")).ti. (239064)  or/1-14 (2553242)
  • 16. Embase processing January 2014-end Jan 2015 using Cochrane 2014 filter February 2015-July 2015 using revised filter Jan 2014 to 31 Jan 2015 Feb 2015- July 2015 inclusive Total retrieved 153610 78516 Records sent directly into Central 54282 9607 Screened RCT or CCT 4324 4515 Screened Reject 94095 63900 Screened Unsure 909 494
  • 17. Study identification: precision Jan 2014 to 31 Jan 2015 Feb 2015-July 2015 inclusive Precision: all records 38.15% 17.99% Precision: screened records 4.55% 7.01% NNR all RCT/CCT records 2.621063 5.559836 NNR screened records only 21.97132 14.26224 January 2014-end Jan 2015 using Cochrane 2014 filter February 2015-July 2015 using revised filter
  • 18. Summary  Many next steps including exploring text mining options  We have achieved improved currency of Embase record availability in CENTRAL  The number of irrelevant and duplicate records will be fewer  Searchers will be able to identify more RCTs more accurately than previously by a rapid search of CENTRAL
  • 19. We need help!  Please visit our project website  http://www.metaxis.com/embasepublic/ Feel free to join the crowd! http://www.metaxis.com/embase/login.php
  • 20. Providing Consultancy & Research in Health Economics http://tinyurl.com/yhec-facebook http://twitter.com/YHEC1 http://www.minerva-network.com/ Thank you julie.glanville@york.ac.uk Telephone: +44 1904 324832 Website: www.yhec.co.uk

Notas del editor

  1. The frequency of terms which appeared in more than 10 records. Terms were analysed by their location within a record: title, abstract, EMTREE headings. Also all terms (independent of their location within a record) were analysed by frequency. The WordStat phrase finding option was used to identify phrases which appeared in more than 10 records. Case occurrence and term frequency–inverse document frequency (tf*idf) were tested. Case occurrence is the frequency of presence of terms in the body of records. The tf*idf statistic reflects how important a word is to a record in a set of records. The tf-idf value increases proportionally to the number of times a word appears in the record, but is offset by the frequency of the word in the set of records. This helps to take account of the fact that some words are more common than others.The highest frequency terms (Randomized controlled trial/ and Controlled study/), which provided the highest number of relevant records, were identified and removed from the analysis. The yield of terms using the case occurrence analysis and the tf*idf analysis were then explored to identify whether different terms would be highlighted by each approach. WordStat clustering option to identify terms which form groups, i.e. words which often appear in close proximity to each other.  Each of these analyses generated candidate terms which were then tested in candidate filters, to ascertain how many of the gold standard records they could identify in Ovid Embase. All of the gold standard records were identified in Embase by searching for their unique identifier.
  2. Case occurrence is the frequency of presence of terms in the body of records. The tf*idf statistic reflects how important a word is to a record in a set of records. The tf-idf value increases proportionally to the number of times a word appears in the record, but is offset by the frequency of the word in the set of records. This helps to take account of the fact that some words are more common than others.The highest frequency terms (Randomized controlled trial/ and Controlled study/), which provided the highest number of relevant records, were identified and removed from the analysis. The yield of terms using the case occurrence analysis and the tf*idf analysis were then explored to identify whether different terms would be highlighted by each approach.
  3. The frequency of terms which appeared in more than 10 records. Terms were analysed by their location within a record: title, abstract, EMTREE headings. Also all terms (independent of their location within a record) were analysed by frequency. The WordStat phrase finding option was used to identify phrases which appeared in more than 10 records. Case occurrence and term frequency–inverse document frequency (tf*idf) were tested. Case occurrence is the frequency of presence of terms in the body of records. The tf*idf statistic reflects how important a word is to a record in a set of records. The tf-idf value increases proportionally to the number of times a word appears in the record, but is offset by the frequency of the word in the set of records. This helps to take account of the fact that some words are more common than others.The highest frequency terms (Randomized controlled trial/ and Controlled study/), which provided the highest number of relevant records, were identified and removed from the analysis. The yield of terms using the case occurrence analysis and the tf*idf analysis were then explored to identify whether different terms would be highlighted by each approach. WordStat clustering option to identify terms which form groups, i.e. words which often appear in close proximity to each other.  Each of these analyses generated candidate terms which were then tested in candidate filters, to ascertain how many of the gold standard records they could identify in Ovid Embase. All of the gold standard records were identified in Embase by searching for their unique identifier.
  4. n March 2013 the contract to identify Embase records was awarded to a consortium made up of Metaxis Ltd, the Cochrane Dementia and Cognitive Improvement Group, and York Health Economics Consortium (YHEC). Searches covering January 2011 to December 2013 identified 33,564 unique Embase records and these were published in CENTRAL, January 2014 Issue 1. All these records were identified from a search in Embase (via Ovid SP) using the Emtree terms Randomized Controlled Trial or Controlled Clinical Trial. It is estimated that 2/3 of records eligible for CENTRAL (according to CERT guidance) from the backlog have been captured and fed into CENTRAL by this search; work to identify the remaining third, (i.e. records not indexed with the RCT or CCT term) is ongoing. The estimates are based on a ‘gold standard’ set of records (made up of large random samples of 1000 Embase records already in CENTRAL across all years). The record set added January issue 1 did not include conference publications; work on these is also ongoing.   Records based on a newly developed highly sensitive search strategy will be fed into CENTRAL from January 2014 on a monthly basis. The search strategy currently is:   1       Random$.ti,ab. 2       randomization/ 3       intermethod comparison/ 4       placebo.ti,ab. 5       (compare or compared or comparison).ti. 6       ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab. 7       (open adj label).ti,ab. 8       ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab. 9       double blind procedure/ 10    parallel group$1.ti,ab. 11    (crossover or cross over).ti,ab. 12    ((match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab. 13    (assigned or allocated).ti,ab. 14    (controlled adj7 (study or design or trial)).ti,ab. 15    (volunteer or volunteers).ti,ab. 16    human experiment/ 17    trial.ti. 18    or/1-17 19    18 NOT tier 1 results [RCT/ OR CCT/] 20    19 not conference abstract.pt. 21     (mammal/ or marine species/ or nonhuman/ or bird/ or animal experiment/ or exp rodent/ or cattle/) not human/ 22    20 not 21  
  5. Animal studies Hi, using the animal studies you sent me I have devised the following. It performs just a little better than the one Anna devised. However, adding in the NOT human/ does mean that it fails to spot lots of animal studies which EMBASE has also tagged with HUMAN. My strategy is line 17, Anna's is line 18. Mine finds all of Anna's and some extra. The test on the 33 you sent me on Sunday show that the filter removes 9, but doesn't remove 24. These are a bunch of studies with Human in as well!!! Not sure whether we want to propose another 2 -tier approach - use line 17 and then do it again without the 'not Human/' to give those a quick eyeball rather than submitting to the reviewers? if you did that my strategy removes 32 in total and  1 slips through - paper about food chemistry. Ideally we need to test this some more on more result sets. 1 exp experimental organism/ 302378 2 animal tissue/ 726327 3 animal cell/ 697222 4 exp animal disease/ 139836 5 exp carnivore disease/ 25207 6 exp bird/ 97046 7 exp experimental animal welfare/ 2288 8 exp animal husbandry/ 34998 9 animal behavior/ 52234 10 exp animal cell culture/ 8989 11 exp mammalian disease/ 78395 12 exp mammal/ 11005108 13 exp marine species/ 3468 14 nonhuman/ 2884891 15 animal.hw. 2256671 16 or/1-15 12120404 17 16 not human/ 2718150 18 (mammal/ or marine species/ or nonhuman/ or bird/ or animal experiment/ or exp rodent/ or cattle/) not human/ 2421425 19 17 not 18 296725 20 18 not 17 0 21 ("2014092492" or "2014102544" or "2014093898" or "23179110" or "2014105508" or "23402514" or "23263675" or "2014093590" or "2014032170" or "2014086649" or "2014086497" or "2014090976" or "2014098222" or "2014100105" or "2014103920" or "23547003" or "23531829" or "23531823" or "2014034485" or "24043704" or "2014037245" or "2014106987" or "2014103562" or "2014091297" or "2014090223" or "2014094000" or "23775276" or "2014083973" or "2014034971" or "2014099859" or "2014081346" or "2014034212" or "2014081091").an. 33 22 17 and 21 9 23 21 not 22 24